INTRODUCTION: Ionotropic glutamate receptors (iGluRs) are cation channels that mediate signal transmission by depolarizing the postsynaptic membrane in response to L-glutamate release from the presynaptic neuron. There are three major iGluR subtypes, and together their activity is pivotal to learning and memory. The first subtype, the AMPA-type receptor (AMPAR), initiates signaling and activates the second subtype, the N-methyl-D-aspartate receptor (NMDAR), thereby admitting Ca 2+ ions that drive synaptic plasticity and ultimately enabling learning. The rapid submillisecond response of the AMPAR permits accurate transmission of high-frequency presynaptic impulses. In the brain, AMPARs preferentially exist as heterotetramers composed of the GluA1 to GluA4 subunits in various combinations. Their signaling properties are dominated by the GluA2 subunit, which is present in the majority of AMPARs, yet the architecture and subunit arrangement of GluA2-containing AMPAR heteromers has thus far been elusive.
RATIONALE: So far, AMPAR structures have been limited to GluA2 homomers. We used a combination of x-ray crystallography and cryogenic electron microscopy (cryo-EM) to obtain structural information for AMPAR heteromers. We first solved crystal structures of the Nterminal domain (NTD) layer, which constitutes the more sequence-diverse upper half of the receptor. Our structures of the GluA2/3 and GluA2/4 NTDs provide atomic resolution of the interface that initiates subunit assembly and reveal tetrameric arrangements in both of these heteromeric combinations that are distinct from known homomers. Cysteine cross-linking confirmed this architecture in full-length receptors and permitted us to determine cryo-EM structures of an intact GluA2/3 heteromer, which is a prominent variety in neural tissue.
RESULTS:
In both GluA2/3 and GluA2/4 NTD crystal structures, the four subunits alternate around a central axis to create a compact O shape that deviates from the loose N shape commonly found in GluA2 homomers. Simulations suggest that the receptor can transition between these two states. Structure-guided cysteine mutants allowed us to trap receptors in the O state and facilitated further analysis by cryo-EM. The GluA2/3 receptor was captured in a ligand-free state and resulted in two models, determined at 8.2 and 10.3 Å.
Both deviate from existing GluA2 homomer structures. Associated with the compact conformation of the NTD layer was a substantial vertical compression of the receptor heteromer, forming distinct interlayer interfaces. Contact points between the NTD and the ligand-binding domain (LBD) suggest that the NTD can contribute to signaling. We also observed a rearrangement of the gating machinery at the level of the LBD layer, and our results provide a structural snapshot of a desensitized receptor in the absence of agonist. Our data indicate that subunit placement in AMPAR tetramers is not strict, unlike in NMDARs, a finding that may extend the functional spectrum of heteromeric AMPARs.
CONCLUSION: The GluA2/3 structure and our simulations emphasize that AMPARs are dynamic complexes. The observed rearrangements of the extracellular region are expected to be of functional consequence in synaptic environments, where the NTD engages various interaction partners. Transitioning between N and O states could break existing contacts and make new ones, thereby affecting AMPAR clustering, a prerequisite for synaptic plasticity. Moreover, the vertical compression observed in GluA2/3 would permit crosstalk between the NTD and LBD, thus incorporating the NTD in allosteric regulation, as has been observed in NMDARs. The sequence-diverse AMPAR NTD, like that of NMDARs, may therefore offer a target for drug development-one that is as yet unexplored.
I
onotropic glutamate receptors (iGluRs) are tetrameric cation channels that mediate fast excitatory signal transmission upon binding presynaptically released glutamate (1) . They are essential for brain development and experience-dependent synaptic plasticity, which underlies learning. iGluR dysfunction is implicated in a number of neurological disorders, including dementia, mood disorders, and epilepsy (2) . Three major subtypes-the a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid, N-methyl-D-aspartate, and kainate receptors (AMPARs, NMDARs and KARs)-each contribute a different component to the synaptic signal (1) . AMPARs mediate the initial depolarization of the postsynaptic membrane, triggering NMDAR activation and the generation of an excitatory postsynaptic potential. The rapid kinetics of AMPARs permit moment-to-moment signaling, and their trafficking to synapses is central to synaptic plasticity (3).
Gating kinetics, ion permeation, and trafficking are set by the subunit stoichiometry and ultimately shape the synaptic response. AMPAR tetramers are composed of the subunits GluA1 to GluA4; the vast majority contain GluA2, which renders the channel impermeable to Ca 2+ , lowers its conductance, and alters its voltage dependence (1, 4) .
Structures of GluA2 homomers have been instrumental in clarifying AMPAR modular architecture (5). The receptor is arranged in domain layers (Fig. 1A) . A twofold symmetrical extracellular region (ECR), composed of the N-terminal domain (NTD) and ligand-binding domain (LBD), is attached to the transmembrane ion channel domain (TMD), which has approximately fourfold symmetry (Fig. 1A) ; a cytoplasmic tail mediates trafficking and anchorage at synapses. The four chains (A to D) in the tetramer are conformationally nonequivalent and probably contribute differently to gating: The AC pair is positioned closer to the ion conduction pore axis (at the level of the LBD and TMD; pore-proximal) than the BD pair is (pore-distal). In NMDARs, which are obligatory heteromers, the GluN2 subunits occupy the BD position (6, 7) and exert a greater pulling force on the gate (8) . The domain architecture of heteromeric AMPARs is currently unknown, and their intersubunit arrangement has only been inferred from modeling studies (9) .
We used x-ray crystallography and singleparticle cryogenic electron microscopy (cryo-EM) in combination with electrophysiology, biochemistry, and coarse-grained simulations to decipher the organization of GluA2-containing AMPAR heteromers.
Crystal structures and organization of the GluA2/3 and GluA2/4 NTD layers Toward resolving the organization of AMPAR heteromers, we first targeted the NTD layer for structural analysis. This membrane-distal domain encompasses 50% of the receptor mass and reaches midway into the synaptic cleft, where it forms a key platform for protein interactions and mediates AMPAR clustering (Fig. 1A) (10, 11) . The bilobate NTD "clamshell" contributes powerful allosteric modulation in NMDARs and thus represents a key drug target (12) .
This highly sequence-diverse domain also initiates iGluR assembly (13) (14) (15) . Although structures for the obligatorily heteromeric NMDAR and KAR NTDs exist (16, 17) , AMPAR NTD heteromers have remained elusive, because they are preferentially rather than obligatorily heteromeric (14, 18) . AMPAR NTDs form tight homodimers (nanomolar dissociation constant) (18) , which have been crystallized previously (14, 15) . We developed a strategy to crystallize AMPAR NTD heteromers from purified homomers (Materials and Methods) and tested all combinations harboring the critical GluA2 subunit.
We obtained crystals of the GluA2/3 and GluA2/ 4 NTDs and determined their structures at 2.1 and 2.5 Å resolution, respectively (table S1). The overall structure of both of these heterodimers is similar to most AMPAR NTD homodimers [average root mean square deviation (RMSD),~1 Å], with the upper lobe (UL) and lower lobe (LL) engaging a dimer interface of~1400 Å 2 ( Fig. 1B  and fig. S1 ). However, they deviate substantially from GluA3 NTD homodimers (average RMSD, 2.5 Å), which are destabilized by like-charge repulsion between Arg 163 residues in the LLs ( fig.  S1 , B and C) (19) . In GluA2/3, salt bridges between GluA3 Arg  163 and GluA2 Asp  145 and H bonds between GluA3 Arg  184 and GluA2 Ala  148 and Glu   149 zip up the heterodimer, explaining why its affinity is higher than that of GluA3 homodimers ( fig. S1 , A to C) (18) . The structures underscore that differences in the LL interface are key determinants of selective heteromerization; UL interactions are mostly conserved between AMPAR paralogs. Both NTD heterodimers assemble into a novel tetrameric arrangement (Fig. 1C) . Whereas GluA2 homomers adopt a loose N shape when viewed from the top (Fig. 1D) (5) , the heteromers adopt a compact O shape with the four subunits alternating around a central axis (Fig. 1C) , an arrangement that is reminiscent of NMDARs (6, 7). In both heteromers, GluA2 lies at specific positions, resulting in a diagonal alignment of the GluA2 loops that cap the dimer interface (Fig. 1C, yellow and black diamond).
The tetrameric interface has three major contact regions, with most of the interactions mediated by the ULs (Fig. 1C and fig. S2 ). In region 1, the GluA2 back (helices J and K) engages the front face of the GluA3 or GluA4 NTD (helix A, beta strand 2, loop after helix I), predominantly via polar and ionic contacts (Fig. 1C and fig. S2B ). These are more extensive for GluA2/4 because of a more compact, near-parallel alignment of the two heterodimers along their vertical axis; in GluA2/3, the two dimers are separated at their LLs, resulting in a tilt angle of~30°relative to GluA2/4 ( fig. S3A) . A key interface element is a loop emanating from helix I (loop I) in the nonGluA2 subunits, where an arginine (Arg 265 in
GluA3 and Arg 264 in GluA4) contacts a highly conserved glutamate (Glu 288 ) on GluA2 helix J ( Fig. 1C and fig. S2B ). GluA2 helix K and the hinge loop that follows it form additional ionic interactions with helix A and beta strand 2 in GluA3 or GluA4; the latter two have been proposed to interact with N-cadherin in GluA2 (20) . In region 2, diagonal contacts are mediated between the LLs of the non-GluA2 subunits via their F helices ( fig. S2C ), similar to the GluN2B interactions in NMDARs (6, 7) . In the more compact GluA2/4 heteromer, helix F interacts with GluA2 LL helix E (region 3). This alternative arrangement is expected to affect NTD interaction with synaptic proteins that mediate AMPAR clustering (10 Cys in GluA4FLAG) are expected to spontaneously cross-link the O shape (Fig. 2, A and B) . Isolation of the heteromers by FLAG immunoprecipitation, followed by Western blotting of the partner subunit on nonreducing SDS-polyacrylamide gel electrophoresis (SDS-PAGE), revealed cross-linked dimers only when both cysteine mutant subunits were present ( Whereas GluA2/4 NTDs crystallized solely in the O shape, the GluA2/3 crystal lattice also contained N-shaped tetramers ( Fig. 2A) . N-shaped GluA2 homotetramers can be cross-linked via the Cys, cross-linked dimers would appear if alternative conformers arose within receptors, whereas clustering of receptors in the O arrangement would give rise to higher molecular weight aggregates. Consistent with the former, we observed cross-linked dimers, but not larger complexes, on SDS-PAGE (Fig. 2 , C and D; lane 6) and tetramers on native PAGE ( fig. S3C ), supporting the existence of alternative arrangements in the AMPAR NTD layer. Rearrangements of the NTD layer have been linked previously to the gating cycle (21) (22) (23) .
N-cross-linked dimers migrated faster on SDS-PAGE than O-cross-linked dimers did, permitting Characterization of the O-shaped GluA2/3 receptor Negative-stain single-particle EM To further validate this new conformation in intact GluA2/3, O-cross-linked GluA2/3 heteromers (GluA2/3 xlink ) were isolated through tandem affinity purifications and subjected to negative-stain single-particle EM (Materials and Methods and fig. S4 ). Three-dimensional (3D) reconstruction yielded a map at~20 Å resolution with a compact O-shaped NTD layer; the GluA2/3 tetrameric crystal structure could be fitted into the EM density unambiguously ( fig. S4C ). A similar NTD organization was observed in 3D reconstructions of GluA2 homomers, although the rest of the receptor differed (24) .
Agonist-induced desensitization triggers rearrangements in the LBD region (25) . Recent AMPAR structures reveal the complete rupture of both LBD dimers upon desensitization and suggest that this is coupled to a rearrangement of the NTD layer (21) (22) (23) . We likewise observed heterogeneity and rupture of the LBD layer in response to saturating L-glutamate, despite trapping the NTDs in the O shape ( fig. S5 , A to C). Hence, a compact NTD layer permits LBD dynamics and is compatible with gating transitions. Reducing the cross-links with 10 mM dithiothreitol (DTT) before the glutamate pulse resulted in additional heterogeneity in the NTD layer, as evident in 2D averages ( fig. S5D ), revealing that the receptor can transition from the O shape.
Coarse-grained simulations
Transitions of the NTD layer between the N and O conformations were also evident in coarsegrained simulations performed with the anisotropic network model (ANM). The ANM calculates accessible conformational changes or global modes of motion, with the first modes describing the energetically most favorable motions (Materials and Methods) (26) . One low-energy mode of a GluA2 homomer [Protein Data Bank identifier (PDB ID) 3KG2], which was previously shown to vertically compress the AMPAR to an NMDAR-like conformation (mode 4) (27), also enables a transition from the N shape to an O-like NTD arrangement ( fig. S6 , left, and Movie 1). Moreover, ANM analysis of the GluA2/3 NTD crystal structure reveals a pathway for the reverse transition from O to N (fig S6, right, and movie S1), further suggesting that AMPARs can populate both conformations.
Functional characterization
To test the functional impact of the O shape, we expressed GluA2/3 or GluA2/4 heteromers in human embryonic kidney (HEK) 293 T cells and recorded whole-cell current (I) responses to rapid glutamate application in oxidizing (copper phenanthroline, CuPhe) or reducing (DTT) conditions. Peak currents were similarly redoxsensitive in O-cross-linked mutants and WT heteromers ( and E). The near equality in the peak amplitude ratios (I max-DTT /I max-CuPhe ) for mutants (crosslinked at either region 1 or region 2; Fig. 1C and  fig. S3B ) and WT heteromers suggests that the receptors trapped in this conformation remain functional.
Desensitization kinetics and recovery from desensitization showed no greater effect of the oxidizing and reducing treatments in the two O-cross-linked heteromers than in the respective wild types (Fig. 2E; fig. S7, C, D Cryo-EM structure of a GluA2/3 AMPAR heteromer Structure determination To determine the molecular organization of GluA2/3, we recorded a cryo-EM data set for GluA2/3 xlink in the ligand-free (apo) state, using a Titan Krios microscope equipped with a Gatan K2 Summit electron detector (Materials and Methods). The direct electron detector allowed us to collect individual subframes and correct for beam-induced motion; 3D classification using maximum likelihood methods was instrumental for isolating different conformations of the sample (28, 29) . 3D classification of 107,939 motion-corrected particles using RELION (30) resulted in three classes with O-shaped NTDs (73,885 particles), one class (16,697 particles) resembling the classical Y-shaped receptor observed in GluA2 homomers (N-shaped when viewed from the top), and one class without AMPAR-like features ( fig. S9 ). Although processing of data from the Yshaped class did not yield a model of sufficient quality, additional steps of 3D classification improved the models for the Oshaped classes, especially at the heterogeneous LBD layer. Two final models, M1 and M2, were obtained. These models differ in both the orientation of the NTD tetramer and the arrangement of the LBDs (Figs. 3 and 4 and figs. S10 and S11). Refinement led to improved maps at 8.25 Å resolution for M1 and 10.3 Å resolution for M2, allowing us to identify individual domains and secondary structure elements, with clear densities for the NTD, LBD, and most TMD helices ( Fig. 3 and fig. S10B ).
Overall architecture of GluA2/3 (M1)
Unlike GluA2 homomers, the heteromer is contracted along its vertical axis (Figs. 3B and 5). A compact NTD assembly closely nests between widely separated LBD dimers, deviating from the loosely arranged (Y-shaped) GluA2 homomer (5) and approaching an NMDAR-like architecture ( Fig. 5B) (6, 7) . We performed rigid-body fitting of nine independent crystal structures into the M1 density (Materials and Methods), resulting in a model composed of two GluA2 NTD protomers, two GluA3 NTD protomers, four LBD protomers, and the TMD of GluA2 (PDB ID 3KG2) (Fig. 3, C to E, and fig. S10 ). Although the NTD protomers were fitted independently, the resulting tetramer closely resembles our NTD crystal structure (RMSD,~3 Å). The distance between the Cb of GluA2 Asn 292 and GluA3 Arg 265 is~6 Å, thus marking the position of the introduced disulfide bond. We observed clear density for the GluA3-specific Nglycosylation site at Asn 35 ( fig. S10, A and B) , signifying that the positioning of the GluA2 and GluA3 subunits is in agreement with the NTD crystal structure (Fig. 1C) .
The diagonal subunit pairs in GluA2 homomers, AC and BD, are conformationally distinct (Figs. 1A and 5A), which is expected to be of functional consequence (5) . In particular, the linker connecting the LBD to TM3 in the BD pair is predicted to have a greater influence on gating (5, 31). In our structure, GluA2 occupies the AC position and GluA3 occupies the BD position. As a consequence, GluA3 is placed pore-distally at the level of the LBD and TMD, whereas GluA2 is pore-proximal (Fig. 5A) . This positioning appears not to be strict in AMPARs, given that GluA2 can also locate to the BD position, according to the GluA2/3 crystal lattice ( Fig. 2A) and the cross-linking data (Fig.  2C) . Hence, rules underlying subunit placement in preferentially heteromeric iGluRs may be relaxed (14) , unlike in obligatory heteromers (6, 7, 17) .
NTD-LBD contacts are apparent in the compact heteromer
One of the most distinctive features of the heteromer is the vertical compression relative to existing AMPAR homomer structures (Fig. 5,   A and B) . To describe this difference in M1, we used the center-of-mass distance between the NTD layer and the gate residue Thr 625 in TM3 as a metric (21) . This distance was 21 Å shorter in GluA2/3 M1 (76 Å) than in the antagonistbound GluA2 cryo-EM structure (97 Å; Fig. 5B ) (22) . The two LBD dimers of the heteromer are splayed apart to accommodate the compact NTD assembly, which partially fills the interlayer cavity that is characteristic of GluA2 homomers.
The compression gives rise to novel interfaces between the NTD and LBD layers (Fig. 5C) , a region that is pivotal to allosteric signal transmission in NMDARs triggered by NTD ligands (6, 7, 12) . The interlayer contact points are approximately equidistant in all chains of M1 (Fig. 5 , B and C) but are more extensive in the BD chains (GluA3). In GluA2, a loop (Ile
444
-Gly
462
) in the LBD projects toward helices D and E at the backside of the NTD. The GluA3 NTDs wedge into the LBD interdimer interface, with NTD helix H contacting LBD helix B. These GluA3 contacts are also apparent in M2, where GluA2 interactions are lost ( Fig. 4A and fig. S11 ). In contrast, complete separation of the ECR layers is evident in GluA2 cryo-EM structures (Fig. 5B) (22) and in a crystal structure of a GluA2-snail toxin complex, in which the toxin pushes the NTD away (31) . Such a separation between the NTD and LBD layers may also occur in the O-shaped receptors, as revealed by ANM mode 6 of GluA2/3 M1 ( fig. S12 and movie S2), further highlighting the flexible nature of the AMPAR ECR. These interlayer dynamics may alter AMPAR interactions at synapses and enable allosteric modulation by the NTD, akin to what occurs in NMDARs.
GluA2/3 in a desensitized state (M2)
Glutamate binding to the LBD (Fig. 1A, star) triggers conformational changes that result in activation and desensitization. Individual LBDs can gate the receptor in response to agonist, and occupation of a single subunit triggers desensitization (32, 33) . The two loosely associated back-to-back dimers rupture upon desensitization in AMPARs and KARs (22, 25, 34) . This dynamic architecture underlies the speed of AMPAR gating (25, 35) .
Heterogeneity in our O-shaped classes largely results from mobility of the LBD layer. Dramatic rearrangements of the LBD layer are apparent in M2; the BC dimer completely ruptures, whereas the AD dimer remains intact, indicating the resting (nondesensitized) state (Fig. 4 and fig. S11 ). The BC chains mimic agonist-bound desensitized GluA2 (21) and provides structural evidence that the receptor can transition into desensitized-like states in the nominal absence of agonist (32, 35, 36) . M1, however, could be fitted best with agonist-free open-cleft LBD conformations (PDB IDs 1FTO and 3UA8; fig. S10C ). The formation of a compact NTD arrangement resembling the GluA2/3 heteromer is evident in a simulation of a GluA2 homomer (PDB ID 3KG2); this is accompanied by a separation of the LBD dimers and a vertical compression of the receptor toward an NMDAR-like conformation, as previously described (27) . The ANM creates springs between interacting residues (Ca within 15 Å), and therefore the LL interdimer interface contacts are maintained. Strain within this interface is apparent, and rearrangement of this region probably follows (movie S1).
Rearrangements of the LBD gating machinery in M1
Rearrangements in the GluA2/3 LBD layer are also evident in M1, which exhibits intact dimers (Fig. 6,  A and B, and fig. S11D ). The interaction between LBD dimers changes during gating, and their tilting apart has been linked to activation (Fig. 6A ) (21, 22) . In GluA2/3 M1, the angle between the LBD dimers is relatively open, substantially deviating from that of the GluA2 ligand-free receptor and surpassing that of the activated-state conformation (by 15°) (Fig. 6A) . ANM-based simulations suggest that this separation is associated with NTD "sinking" (M1 mode 6) ( fig. S12 and movie S2) . Together, these data raise the possibility that NTD-LBD interlayer dynamics affect the gating machinery.
When viewing the LBD layer from the top, a new arrangement is apparent. The channel-active state has been suggested to be accompanied by an irislike opening of the LBD tetramer interface, formed between the G helices of chains A and C (21, 22) . These helices, which are arranged head-on in the activated (and resting) states of GluA2 homomers, lie parallel in GluA2/3 M1, essentially closing the LBD gating ring (Fig. 6B and Movie 2). This suggests that the receptor can access a multitude of conformations, with both a separation of the LBD dimers and an open gating ring required for activation.
Conclusion
Here we present the first views of AMPAR heteromers containing the GluA2 subunit, which is the prevailing variety in the brain. We have delineated the most sequence-diverse subunit interface at atomic resolution and have shown that heterodimers associate to form a tetramer with the four subunits alternating around the pore axis. Although GluA2 occupies the pore-proximal (AC) position, subunit placement does not appear to follow strict rules, unlike in obligatorily heteromeric iGluRs (6, 7, 17) . Whether and how these relaxed assembly rules affect signaling in preferentially heteromeric iGluRs (AMPARs and low-affinity KARs) is now an open question. Ligand-free GluA2/3 was captured in resting (M1) and desensitized (M2) conformations, providing structural evidence that the apo receptor can transition between states. Overall, its architecture departs from the classical Y shape and approximates that of NMDARs. We have described a conformational trajectory, supported by ANM simulations, in which the NTDs transition from an N shape into a compact O assembly, which is associated with a vertical compression (Fig. 6C and Movie 1). This receptor conformation could be of functional consequence. First, the interfaces resulting from approximation of the NTD and LBD could permit allosteric coupling within the ECR and provide a novel substrate for AMPAR therapeutics, analogous to that in NMDARs (12) . Second, because the NTD mediates AMPAR clustering at synapses and dendritic spine dynamics (11, 20) , the transition from N to O could alter a strategic docking platform for synaptic interaction partners, including pentraxins (11) and AMPAR auxiliary subunits (37) . The GluA2/3 structure opens avenues to further understanding of AMPAR signal transmission.
Materials and methods

Cloning, expression, and protein purification
The plasmids used for full-length receptors were (i) the rat Gria2 cDNA (flip splice variant, fully edited at the R/G and Q/R editing sites) containing an N-terminal c-myc tag or an N-terminal FLAG tag in the pIRES2-EGFP (plasmid internal ribosomal entry site 2-enhanced green fluorescent protein) vector; (ii) the rat Gria3 cDNA (flip, R439G) with an N-terminal FLAG tag in the pRK5 vector (for protein production and biochemical assays) or in the pIRES2-mCherry vector (for electrophysiological studies); and (iii) the rat GluA4 cDNA (flip) with and without an N-terminal FLAG tag in the pRK5 vector. All site-directed mutagenesis was performed on these constructs; mutants included GluA2myc N292C, V209C, and N292C+V209C; GluA3FLAG R265C and GluA4FLAG R264C; and GluA4 S172C and Q175C.
For crystallization, GluA2 NTD (residues 1 to 379 of the mature protein), GluA3 NTD (1 to 380 of the mature protein), and GluA4 NTD (1 to 380 of the mature protein) were produced in stably transfected HEK293S-GnTI -cells, as previously described (18) . Briefly, purification consisted of cross-flow concentration and dialysis (in 1 M NaCl and 50 mM tris at pH 8), followed by affinity (His-trap HP column, GE Healthcare) and size exclusion chromatography (S200, GE Healthcare). Oligosaccharides were removed from the protein sample by means of enzymatic EndoH treatment in 100 mM sodium acetate (pH 5.2) and, for further purification, size exclusion chromatography in 50 mM Hepes (pH 7.4) and 150 mM NaCl. For the purification of the full-length crosslinked receptor, GluA2myc N292C (flip, R/G, Q/R) and GluA3FLAG R265C (flip, R439G) plasmids were transfected into HEK293S-GnTI -cells (38) grown in suspension. Cell culture and transfection followed recently described protocols (39, 40) . For 1 liter of cells (3 × 10 6 cells/ml), a transfection mixture was prepared containing 0.8 mg of GluA2 plasmid, 0.2 mg of GluA3 plasmid, and 3 ml of polyethylenimine "Max" (Polysciences) at 1 mg/ml in 80 ml of hybridoma medium (Life Technologies). Before transfection, cells were centrifuged at 400g and supernatant was removed. Cells were resuspended in the transfection mixture and added to 670 ml of freestyle medium supplemented with 1% fetal bovine serum. Cells were grown at 37°C for 60 hours and harvested by centrifugation. Cell pellets were resuspended in ice-cold phosphatebuffered saline (PBS) containing 10 mM CuPhe (mixed from CuCl 2 and 1,10-phenanthroline at a 1:3 molar ratio; values in the text represent the CuCl 2 concentration) and harvested by centrifugation at 800g. Cells were lysed for 90 min at 4°C in 25 mM tris (pH 7.4), 150 mM NaCl, 1% n-dodecylb-D-maltoside (DDM), 1× protease inhibitor cocktail (Roche), 30 mM N-ethylmaleimide (NEM), and 1 mM phenylmethanesulfonyl fluoride (PMSF). After centrifugation, the supernatant was incubated with anti-FLAG M2 beads (Sigma) for 2 hours at 4°C. The sample was eluted with buffer containing 0.15 mg/ml FLAG peptide (Sigma), 0.25% DDM, 25 mM tris (pH 7.4), and 150 mM NaCl. To isolate the heteromeric pool of receptors, a second affinity purification was performed, incubating with anti-myc affinity beads (Pierce). The sample was eluted with 0.5 mg/ml c-myc peptide (Pierce), 0.25% DDM, 25 mM tris (pH 7.4), and 150 mM NaCl. The eluted sample at 0.03 mg/ml showed two bands in nonreducing SDS-PAGE, corresponding to monomers and disulfide-linked dimers ( fig. S4A) .
Crystallization, data collection, and structure determination of NTD heteromers For GluA2/3 crystallization, GluA3 NTD was diluted to 5 mg/ml, and GluA2 NTD (0.5 mg/ml) was added and concentrated in sequential steps until the GluA2/3 molar ratio reached 1:1, achieving a final concentration of 22 mg/ml. For GluA2/4 heteromers, both GluA2 and GluA4 NTDs were diluted to 0.5 mg/ml, mixed at 1:1 molar ratio, and concentrated to 14 mg/ml. Crystallization screens were set in 96-well MRC plates in 150-plus-150 nl drops, with the protein at 12.5 mg/ml. GluA2/3 crystals appeared in drops containing 14 to 16% PEG-3350 (polyethylene glycol, molecular weight 3350), 0.27 M ammonium sulfate, and 0.1 M bicine (pH 9). GluA2/4 crystals grew in 17% PEG-3350 with 0.1 to 0.35 M ammonium sulfate. Crystals were cryoprotected with 20% glycerol and flashfrozen in liquid nitrogen. Data collection was performed in Diamond Light Source at the I04-1 beamline (0.9163 Å wavelength), and data were collected to 2.12 (GluA2/3) and 2.5 Å resolution (GluA2/4). GluA2/3 data were integrated, scaled, and reduced with Xia2 (41). GluA2/4 data were integrated with iMosflm (42) and scaled and reduced with AIMLESS (43). The GluA2/3 structure was determined by molecular replacement, using monomers from the structures with PDB IDs 3HSY (GluA2) (18) and 3O21 (GluA3) (19) as search models in MOLREP (44) . Structures 3HSY (GluA2) and 4GPA (GluA4) (45) were used as search models in PHASER (46) to phase the GluA2/4 structure by molecular replacement. Both structures were refined using REFMAC5 (47) from the CCP4 suite of programs (48) , and manual modifications were performed with COOT (49) . The GluA2/3 and GluA2/4 structures were refined to an R work /R free (R factor over free R factor) of 19.2%/23.1% and 17.4%/23.8%, respectively, with both presenting good geometry as defined by the Ramachandran plot. TLS and individual isotropic B factors were refined in both structures. The GluA2/4 structure presented pseudosymmetry (as shown by the Patterson map) and pseudomerohedral twinning with a monoclinic cell with a b angle close to 90°. To overcome this problem, refinement was carried out by computing the twinning fraction in REFMAC5 (twinning fraction of 0.5).
Disulphide cross-linking experiments with full-length heteromers
Mutants were transfected into HEK293T cells by using the Effectene transfection reagent (Qiagen), at a 1:4 ratio of the GluA3-pRK5: GluA2-pIRES2-EGFP plasmids. After expression for~60 hours, cells were treated with ice-cold PBS containing 10 mM CuPhe (as above) for 45 min before harvesting and lysing in 25 mM Hepes (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and 50 mM NEM, together with PMSF and protease inhibitor cocktail (Roche). The lysate was incubated overnight with anti-FLAG M2 magnetic beads and washed three times with lysis buffer; protein was eluted with 2× SDS-PAGE loading dye. After 10 min incubation at 70°C, samples were loaded into 3 to 8% tris acetate polyacrylamide gels, transferred into nitrocellulose membranes, and probed with the Millipore antibodies to GluA2 (AB1768) and GluA4 (AB1508). The lightchain MAB-201P secondary antibody was used. Signal was achieved using Supersignal WestDura (Thermo Scientific), and images were recorded in a ChemiDoc MP system (BioRad). For native gels, cells were lysed in 1% DDM instead of Triton X-100. Lysate was incubated with anti-FLAG M2 magnetic beads, washed three times, and eluted with 6 volumes of 0.1 mg/ml FLAG peptide in native PAGE sample buffer supplemented with 1% DDM. Samples were loaded into native PAGE Novex 4-to-16% bis-tris gels and run following the manufacturer protocol. Samples were transferred to polyvinylidene difluoride membranes before blocking with 5% milk and probed with GluR2 Cterminal antibody (Sigma). Signal development was carried out as described above. Controls including SDS and SDS+DTT were also included in the gel.
EM sample preparation and data acquisition
For negative staining, 4-ml aliquots of sample at 0.03 mg/ml were stained using 0.75% (w/v) uranyl formate on glow-discharged 400-mesh copper grids (Agar Scientific) covered with a thin layer of carbon. When appropriate, samples were mixed with 100 mM glutamate immediately before grid preparation, or they were incubated with 10 mM DTT for 1 hour at 4°C before adding 100 mM glutamate. Images were recorded using a Tecnai T12 electron microscope (FEI) operated at 120 kV with a nominal magnification of 30,000× (pixel size, 3.286 Å) for the cross-linked apo and glutamate samples and at 26,000× (pixel size, 3.84 Å) for the glutamate+DTT samples. All data were collected at~1-mm defocus, 1-s exposure, and 20 electrons per square angstrom per second, using a Gatan Ultrascan 1000 2K × 2K with a 14-mm pixel size. For cryo-EM, R1.2/1.3 Quantifoil 300-mesh copper grids covered with a thin layer of carbon were rendered hydrophilic by means of glow discharge. Vitrified specimens were prepared using a Vitrobot MKIII (FEI) at 100% humidity and 4°C, in which 4-ml samples at 0.03 mg/ml were incubated for 1 min, blotted for 3 s, and plunge-frozen in liquid ethane. Images were recorded on a Titan Krios microscope (FEI) operated at 300 kV and using a K2 Summit detector in single-electron counting mode, resulting in a calibrated magnification of 28,409× (1.76 Å per pixel). The K2 Summit detector was mounted after a Gatan Imaging Filter (GIF Quantum energy filter) and a slit width of 20 eV was used to remove inelastic scattered electrons. A dose rate of 1.6 electrons per square angstrom per second and a total exposure of 40 electrons per square angstrom were used, with a total of 20 movie frames recorded. Defocus values ranged from 1 to 4 mm.
Image processing and model building
In the analysis of images from negatively stained samples, EMAN2 (50) was used for initial manual and semiautomated particle picking, and RELION (30) was used for all subsequent steps. Initial 2D representative classes were used for automated selection of particles in RELION. Four to six rounds of false-positive elimination by reference-free 2D classification rendered 34,836 particles for the GluA2/3 xlink , 27,648 particles for the glutamate-treated sample, and 36,966 particles for the sample treated with glutamate and DTT. For the 3D classification, two different initial models were used. First, an O-shaped model was built by using the TMD and LBD of the GluA2 crystal structure (PDB ID 3KG2) and our tetrameric crystal structure of the GluA2/3 NTD. A second model, with an N-shaped NTD, was generated using the whole GluA2 homomer structure (PBD ID 3KG2). Both models were low pass-filtered to 60 Å. Using these as starting references for 3D classification in the GluA2/3 xlink data set , we obtained classes with O-like arrangements at the NTD layer. For the remaining data sets, the O model was used as the starting model for 3D classification. All data sets were divided into five classes, and the cleanest model was chosen for refinement. Both GluA2/3 xlink and glutamatetreated GluA2/3 xlink samples yielded maps at aad3873-7
Movie 2. Morph animation showing conformational changes in the LBD layer revealed by GluA2/3 M1. The "morph" command in PyMOL (61) was used to generate a series of intermediate conformations between the LBD layer of a GluA2 homomer (PDB ID 4U2P) and that of GluA2/3 M1. A rotation of the two dimers about the interdimer interface is apparent, resulting in an approximation of G helices in chains A and C (orange). This is accompanied by an opening of the roll angle between the LBDs. ~20 Å resolution, with models containing 9211 particles for the GluA2/3 xlink and 6684 particles for the glutamate-treated sample. To further validate the model, an NTD-lacking map, filtered at 60 Å, was generated and used as the initial model for the refinement. The resulting map showed an O-shaped structure that appeared unambiguously after refinement. A population of Y-shaped receptors also appeared in the 3D classification, but the number varied randomly with the sample preparation.
For cryo-EM, movie frames for each micrograph were aligned for whole-image drift using MOTIONCORR (51) , and contrast transfer function parameters were estimated with Gctf (52). EMAN2 was used for initial manual and semiautomated particle picking, and RELION was used for 2D classification, as well as for subsequent classification and refinement, unless otherwise stated. Resulting 2D classes were fed as references for automated picking with RELION. Particles were extracted in a 288 Å box for reference-free 2D classification, which rendered 107,939 particles to be used for subsequent 3D analysis. To produce a starting reference free of bias, an ab initio model was created, starting with representative 2D classes in EMAN2. Beam-induced movement correction and B-factor weighting were performed by applying statistical movie processing in RELION (30) . 3D classification resulted in three classes featuring O-like NTDs (73,885 particles) and one class resembling the classical Y-shaped receptor (16, 697 particles) (fig. S9 ). The fifth class contained particles forming an uninterpretable model and was therefore discarded. Further 3D classification of the O-like classes by using a soft mask allowed us to eliminate false positives and to obtain two improved classes with two different conformations at the LBD layer ( fig. S9 ). The soft-edge mask was created with the relion_mask_create command, extending the map by five pixels with a fivepixel fall-off. The two classes were further classified into three classes to improve homogeneity; we thereby obtained two maps that, after refinement, produced the final models, M1 and M2, with overall resolutions of 8.25 and 10.3 Å, respectively (figs. S10 and S11). Reported resolutions were calculated using the Fourier shell correlation (FSC) criterion of 0.143 (53) . Convolution effects on the FSC curves were corrected by means of high-resolution noise substitution ( fig. S10) (54) . Maps were corrected for the modulation transfer function of the detector and sharpened by applying a negative B-factor. Xmipp (55) was used to calculate the FSC of the model versus the map. Local resolution analysis was performed with ResMap (56) . A tilt-pair validation was performed to confirm the correctness of the map ( fig. S10F ).
Using Chimera (57), nine independent crystal structures of the different domains were rigidbody fitted into the M1 model. The NTD layer was fitted by using the GluA2 NTD (PDB ID 3HSY, chain B) (18) and GluA3 NTD (PDB ID 3O21, chain D) (19) . For the TMD layer, coordinates of the antagonist-bound GluA2 homomer (PDB ID 3KG2) (5) were used with the reentrant pore loop removed, for which density was absent. For the LBDs, over 100 crystal structures in complex with different ligands are currently available, displaying different levels of clamshell closure. We used the program NORMA (58) to assign the conformation of each LBD protomer in the EM map. The ligand-free GluA2 LBD monomer (PDB ID 1FTO) (59), placed in each of the four LBD positions in the EM map, was subjected to coordinate normal mode calculation coupled to a scoring system that assessed the fitness of each conformation to the EM map. For GluA2, the resulting conformation corresponded to the ligand-free state (PDB ID 1FTO, chain B). For GluA3, the resulting conformation was similar to GluA2 in complex with a 6-aminoquinazolinedione sulfonamide antagonist (PDB ID 3UA8) (60) , with an opening angle higher than in any existing GluA3 LBD structure and similar to that of the structure with PDB ID 1FTO. The same coordinates were used in the fitting of M2; however, the resolution of M2 did not allow for a calculation of the LBD cleft angle. Final PDBs were created by renumbering and merging the fitted PDBs in PyMOL (61) . Although the GluA2 and GluA3 C termini were aad3873-8 29 present, no corresponding densities were observed in any of the cryo-EM maps, suggesting that these 50 amino acid segments are disordered.
Electrophysiology, data acquisition, and analysis HEK293T cells were cotransfected with GluA2 (flip) and GluA3 (flip, R439G) or GluA4 (flip) plasmids by using the Effectene transfection reagent (Qiagen), at ratios favoring the formation of heteromers (checked for each cell by recording the current-voltage characteristics of the responses in the presence of intracellular spermine).
Current responses of whole lifted cells, voltageclamped at -60 mV, were elicited by fast application of 10 mM L-glutamate via a q tube and recorded using an Axopatch-1D, -200B, or -700B amplifier, a Digidata1322/1440A interface, and pClamp 9.2/10.5 software (Molecular Devices). Cells were perfused with external solution containing (in mM) NaCl (145), KCl (3), CaCl 2 (2), MgCl 2 (1), glucose (10) , and Hepes (10), adjusted to pH 7.4 with NaOH and supplemented with either 10 mM CuPhe or 10 mM DTT. Electrodes were fabricated from borosilicate glass (1.5-mm outer diameter, 0.86-mm inner diameter; Science Products GmbH) pulled with a PC-10 vertical puller (Narishige). When filled with the internal solution-containing (in mM) CsF (120), CsCl (10), EGTA (10), ATP-sodium salt (2), Hepes (10), and spermine (0.1), adjusted to pH 7.3 with CsOH-they had a final resistance of 2 to 5 megohms. The oxidizing (reducing) potency of the CuPhe (DTT) solutions was checked routinely by using the GluA2 S729C mutant (62) .
To assess desensitization kinetics, responses to 100-ms glutamate pulses were recorded, and the current decay during the agonist application was fitted with a one-or two-exponential function to obtain the (weighted) time constant of desensitization. Recovery from desensitization was tested by using a two-pulse protocol with a desensitizing 100-ms pulse, followed by a 10-ms pulse in increasing intervals. The relative responses to the second pulse (an average of three consecutive runs) were plotted against the time elapsed from the end of the first pulse and fitted by the Hodgkin-Huxley equation, as in (63) .
The effect of forming and breaking the introduced Cys bond was examined by recording each cell under both oxidizing and reducing conditions and comparing the parameters with the corresponding WT receptors by means of repeated-measures two-way analysis of variance. This provided information about the effect of the mutation, the treatment (oxidation versus reduction), and the interaction of the two factors-i.e., whether the effect of the treatment is different for the mutant and the WT.
ANM analysis
Normal mode analysis is a method for determining modes of motion that are accessible to a protein, given a particular starting structure and a model describing forces between atoms.
The ANM is a coarse-grained elastic network model with a single node for each amino acid residue. Interactions are modeled as uniform harmonic springs between residues within a cutoff (15 Å between Ca atoms) (26, 64) . The Hessian matrix of force constants (second derivative of the energy potential function) is decomposed to give a unique set of normal modes. Modes are represented by 3N-dimensional eigenvectors u k (for N residues in 3D space) with corresponding eigenvalues l k . The first modes (those with low eigenvalues) describe low-energy global motions, and the higher-eigenvalue modes describe less favorable local deformations. Conformations R (k) along a given mode k were generated using the equation R (k ) = R (0) ± (sl -1/2 u k ), where R (0) is a 3N-dimensional vector representing the initial coordinates, and s is a scaling constant that can be adjusted to fit experimental data (65) . Normal mode analysis with the ANM was carried out using the ANM server (66) and Python extension ProDy (67), as previously described (27) . The similarity between conformations in ANM mode 4 and the GluA2/3 NTD crystal structure was assessed using the Normal Mode Wizard (67) in VMD (68) .
Comparing normal modes with transitions between N and O crystal structures
Transitions were calculated as the displacement vector for all corresponding Ca atoms required to interconvert the two aligned structures [the N-shaped NTD layer from the GluA2 homomer (PDB ID 3KG2) and our O-shaped GluA2/3 NTD crystal structure]. The extent of directional overlap between a displacement vector d and a normal mode vector u k , generated from one of the aligned structures, could then be calculated as the correlation cosine d·u k (shown as blue bars in fig. S6 ). To assess whether a combination of modes would better describe the transition than any given single mode, we also calculated cumulative overlaps as the square root of the sum of squared overlaps (red curves in fig. S6 ); no noticeable improvement was evident. These calculations were also carried out using Python with ProDy (67).
LBD transitions
Conformational changes within the LBD layer were calculated as transitions between aligned structures from GluA2/3 M1 and either the apo GluA2 homomer (PDB ID 4U2P) or an antagonist-bound GluA2 homomer (PDB ID 3KG2), as described above for the NTD transition. The correlation cosine between these transitions was 0.95, confirming that they follow a shared pathway. The transition between the antagonist-bound GluA2 homomer and GluA2/3 M1 was also calculated using the "morph" command of PyMOL, which was also used for the creation of Movie 2.
